On the evening of March 19, in CCTV news 1 + 1, Bai Yansong connected with Ma Xuejun, researcher of China CDC. 20 days ago, a team of volunteer experts from the Red Cross Society of China, including Ma Xuejun, went to Iran to teach China’s experience in epidemic prevention and control. Ma Xuejun said that insufficient medical and protective materials, medical staff and beds are the biggest challenges facing Iran’s epidemic prevention and control.
According to Ma Xuejun, Iran’s network registration and reporting system shows that the epidemic situation in Iran is in a rapid growth period, and 22.5 million people have been screened nationwide, including 1.5 million people with fever symptoms at least.
When connecting, he said that from a large point of view, Iran’s prevention and control measures are gradually strengthening, such as comprehensive mobilization plan, home quarantine policy, travel restrictions, as well as improving detection capacity and building a shelter hospital. From a small point of view, Iranian officials are wearing masks, and more and more people are wearing masks. “These are all Chinese experiences, which are also worthy of affirmation.”
According to the data of the Ministry of health of Iran, by the noon of the 18th local time, 17361 cases had been confirmed, 1135 cases had died and 5710 cases had been cured.
From the available data, Iran has a high mortality and cure rate. According to Ma Xuejun, there are two main reasons for the high fatality rate. One is that all suspected cases have not been detected, and the actual number of people infected exceeds the number reported. The other is that the shortage of medical equipment, instruments, drugs, medical staff and beds in ICU has affected the cure level.
With regard to the high cure rate, Ma Xuejun analyzed that the discharge standards of patients in Iran and China are different. There is no nucleic acid test in Iran’s discharge standards, but in China, patients need to have two negative nucleic acid tests to be discharged. Loose discharge standards also contain risks. According to him, Iran has taken a compromise approach and built many centralized and isolated observation points, with about 10000 beds. Patients admitted and discharged continue to be observed intensively.
According to reports, in the past 20 days in Iran, the Chinese expert team and experts from who, Iran investigation team, Iran’s Ministry of health, local designated hospitals and other units have conducted many in-depth exchanges, taking this opportunity to learn about the current situation of prevention and control in Iran at all levels, and also promote China’s prevention and control experience. “I’m glad that China’s prevention and control experience has been highly recommended by who and highly recognized by the Ministry of health of Iran.”
“When we first arrived in Iran, there were only three local laboratories capable of testing, and now it has expanded to 50, with a daily testing capacity of 6000 people.” Ma said, however, given the huge number of infections, Iran’s existing capacity is far from meeting the needs of testing, and many patients with mild illness isolated at home have not been effectively tested. Because of this, who is calling on more countries, including China, to actively support Iran in its fight against the epidemic.
Referring to the trend of Iran’s epidemic situation, Ma Xuejun pointed out that at present, the local beds and testing reagents can not meet the needs of “testing to the full” and “receiving to the full” recommended by China’s experience. He repeatedly stressed in the connection that the key to control the epidemic in Iran depends on the sustainability of prevention and control measures, including the cooperation of the people, the publicity of the government and the implementation of laws and regulations. On the other hand, to solve or at least alleviate the shortage of testing reagents, personal protection and medical materials is the biggest challenge facing Iran.